We are live on ! Find out more
PP

Paloma Partners Portfolio holdings

AUM $510M
1-Year Est. Return 286.05%
This Fund
S&P 500
This Quarter Est. Return
+3.59%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$10.2B
AUM Growth
+$2.21B
Cap. Flow
+$1.91B
Cap. Flow %
18.7%
Top 10 Hldgs %
42.15%
Holding
2,326
New
523
Increased
761
Reduced
552
Closed
381

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$88.6M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$55.2M
3
AMZN icon
Amazon
AMZN
+$50.7M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$50.4M
5
AAPL icon
Apple
AAPL
+$27.4M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 4.46%
2 Industrials 3.74%
3 Financials 3.69%
4 Healthcare 3.55%
5 Technology 3.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TROW icon
301
PUT
T. Rowe Price
TROW
$25.5B
$4.21M 0.04%
56,000
COF icon
302
CALL
Capital One
COF
$127B
$4.19M 0.04%
48,000
WAT icon
303
Waters Corp
WAT
$36.4B
$4.18M 0.04%
31,127
+24,660
+381% +$3.52M
VMC icon
304
CALL
Vulcan Materials
VMC
$36.9B
$4.17M 0.04%
33,300
VMC icon
305
PUT
Vulcan Materials
VMC
$36.9B
$4.17M 0.04%
33,300
GD icon
306
PUT
General Dynamics
GD
$105B
$4.14M 0.04%
24,000
+16,000
+200% +$2.62M
WBA
307
CALL
DELISTED
Walgreens Boots Alliance
WBA
$4.14M 0.04%
50,000
+35,000
+233% +$2.89M
DE icon
308
PUT
Deere & Co
DE
$169B
$4.12M 0.04%
40,000
WCG
309
DELISTED
Wellcare Health Plans, Inc.
WCG
$4.12M 0.04%
30,072
+11,492
+62% +$1.46M
V icon
310
Visa
V
$689B
$4.11M 0.04%
52,692
+36,480
+225% +$2.93M
HCA icon
311
HCA Healthcare
HCA
$86.4B
$4.11M 0.04%
55,504
-44,961
-45% -$3.37M
MSFT icon
312
CALL
Microsoft
MSFT
$2.89T
$4.1M 0.04%
66,000
-382,100
-85% -$23M
CPAY icon
313
Corpay
CPAY
$24.8B
$4.09M 0.04%
+28,870
New +$4.52M
PARA
314
PUT
DELISTED
Paramount Global Class B
PARA
$4.07M 0.04%
64,000
-230,600
-78% -$13.7M
CUK
315
DELISTED
Carnival PLC
CUK
$4.06M 0.04%
+79,368
New +$3.95M
XLF icon
316
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
$4.06M 0.04%
174,509
-140,491
-45% -$3.01M
ROK icon
317
CALL
Rockwell Automation
ROK
$51.9B
$4.03M 0.04%
30,000
ROK icon
318
PUT
Rockwell Automation
ROK
$51.9B
$4.03M 0.04%
30,000
TFC icon
319
PUT
Truist Financial
TFC
$63.7B
$4.02M 0.04%
85,400
+30,000
+54% +$1.28M
CLGX
320
DELISTED
Corelogic, Inc.
CLGX
$4.01M 0.04%
108,780
+78,659
+261% +$3.04M
IBM icon
321
CALL
IBM
IBM
$204B
$3.98M 0.04%
25,104
+16,736
+200% +$2.55M
UAL icon
322
United Airlines
UAL
$39.1B
$3.98M 0.04%
54,645
-85,903
-61% -$5.47M
EXPD icon
323
CALL
Expeditors International
EXPD
$22.4B
$3.97M 0.04%
75,000
+11,000
+17% +$575K
CVS icon
324
CALL
CVS Health
CVS
$137B
$3.95M 0.04%
50,000
+34,000
+213% +$2.75M
MENT
325
DELISTED
Mentor Graphics Corp
MENT
$3.93M 0.04%
106,530
+56,468
+113% +$1.84M

Similar funds

Paloma Partners's Q4 2016 Portfolio in Review

As of Q4 2016, Paloma Partners held 2,326 positions worth $10.2B, up 28% from $7.99B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Paloma Partners deployed $1.91B of net new capital in Q4 2016, opening 523 new positions and adding to 761 existing holdings. Its largest new stake was NXP Semiconductors: 253,000 shares worth $24.8M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 4.5% of assets, up from 3.4% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was KLA, an estimated $30.4M trimmed.

  • Paloma Partners's largest Q4 2016 buy was NXP Semiconductors: 253,000 shares worth $24.8M.
  • Paloma Partners added most to Biogen in Q4 2016, an estimated $88.6M increase.
  • Paloma Partners's biggest Q4 2016 reduction was KLA, cutting an estimated $30.4M.
  • Paloma Partners fully exited St Jude Medical in Q4 2016, selling an estimated $13.5M.
  • Paloma Partners's ten largest holdings make up 42% of its $10.2B portfolio in Q4 2016.
  • Paloma Partners opened 523 new positions and closed 381 in Q4 2016.
  • Paloma Partners's portfolio value rose 28% quarter-over-quarter to $10.2B.

Based on Paloma Partners's 13F filing for Q4 2016, filed 14 Feb 2017.